OTCMKTS:ESALY Eisai (ESALY) Stock Price, News & Analysis $61.51 -1.33 (-2.11%) As of 01/30/2023 Add Compare Share Share Stock Analysis Stock Analysis About Eisai Stock (OTCMKTS:ESALY) Get Eisai alerts:Sign Up Key Stats Today's Range$61.00▼$63.2950-Day Range$61.51▼$61.5152-Week Range$36.88▼$73.90Volume331,800 shsAverage Volume60,916 shsMarket Capitalization$17.64 billionP/E Ratio70.70Dividend Yield1.43%Price TargetN/AConsensus RatingN/A Company Overview Eisai Co., Ltd. is a Japan-based pharmaceutical company that researches, develops, manufactures and markets prescription medicines and healthcare products. The company focuses primarily on neuroscience and oncology, with additional products in areas such as neurology, gastrointestinal disorders and preventive healthcare. Eisai’s marketed medicines include Leqembi (lecanemab), an Alzheimer’s disease treatment developed in collaboration with Biogen; Dayvigo for insomnia; Fycompa for epilepsy; and Halaven for certain cancers. Eisai also co-develops and commercializes Lenvima, an oncology medicine, with Merck & Co. The company’s healthcare portfolio includes over-the-counter products and other consumer health offerings in selected markets. Founded in Japan in 1941, Eisai has expanded its operations internationally and serves patients and healthcare professionals across Japan, the United States, Europe and other markets in Asia and around the world. Its research activities are concentrated on areas with significant unmet medical needs, including dementia, neurological diseases and cancer.AI Generated. May Contain Errors. Read More Receive ESALY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Eisai and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. ESALY Stock News HeadlinesEisai Co. Evaluates Fycompa’s Safety in New Clinical StudyOctober 27, 2025 | tipranks.comEisai Begins Rolling SBLA Submission For LEQEMBI IQLIK Subcutaneous AutoinjectorSeptember 3, 2025 | finanznachrichten.deEvery Major Market Reset Had These 3 Warning Signs First. All 3 Are Flashing Right Now.U.S. debt is closing in on 38 trillion as foreign buyers pull back, tightening liquidity across markets. The 2026 Munich Security Report just called the global order Under Destruction, citing trade fragmentation and weakened institutions. Meanwhile, central banks are buying gold at record levels without explanation, and gold has outpaced the S&P 500 in 2026.September 14 at 1:00 AM | Golden Crest Metals (Ad)EcoNaviSta, Inc. Supports Eisai Co., Ltd.’s Tender OfferMarch 14, 2025 | tipranks.comEisai stock price target cut to JPY5,000 at Citi, retains Buy ratingFebruary 10, 2025 | msn.comEli Lilly's Alzheimer's Drug Raises Hopes but Faces Regulatory Hurdles in EuropeOctober 14, 2024 | finance.yahoo.comAlzheimer's drug Leqembi promises to give patients more time, but they face a long road to treatmentSeptember 8, 2024 | cnbc.comThis matcha set helped me break my coffee addiction and I’ve never looked backSeptember 2, 2024 | msn.comSee More Headlines ESALY Stock Analysis - Frequently Asked Questions How have ESALY shares performed this year? Eisai's stock was trading at $61.51 at the beginning of the year. Since then, ESALY shares have increased by 0.0% and is now trading at $61.51. How were Eisai's earnings last quarter? Eisai Co., Ltd. (OTCMKTS:ESALY) released its earnings results on Wednesday, August, 4th. The company reported $1.34 earnings per share for the quarter, topping the consensus estimate of $1.09 by $0.25. The firm earned $1.82 billion during the quarter. Eisai had a net margin of 4.11% and a trailing twelve-month return on equity of 3.86%. How do I buy shares of Eisai? Shares of ESALY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Last Earnings8/04/2021Today9/14/2026Fiscal Year End3/31/2027Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorHealthcare Industry Pharmaceuticals Sub-IndustryPharmaceuticals Current SymbolOTCMKTS:ESALY CIK948406 Webwww.eisai.co.jp Phone(133) 817-3700Fax813-3811-6032Employees11,322Year Founded1941Profitability EPS (Trailing Twelve Months)$0.87 Trailing P/E Ratio70.70 Forward P/E Ratio32.37 P/E Growth2.46Net Income$426.79 million Net Margins4.11% Pretax MarginN/A Return on Equity3.86% Return on Assets2.50% Debt Debt-to-Equity Ratio0.10 Current Ratio2.20 Quick Ratio1.77 Sales & Book Value Annual Sales$6.74 billion Price / Sales2.62 Cash Flow$2.68 per share Price / Cash Flow22.94 Book Value$23.94 per share Price / Book2.57Miscellaneous Outstanding Shares286,770,000Free FloatN/AMarket Cap$17.64 billion OptionableNot Optionable Beta0.31 Social Links 10 Stocks Powering The Next AI Boom The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation. Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.Get This Free Report This page (OTCMKTS:ESALY) was last updated on 9/14/2026 by MarketBeat.com Staff. From Our PartnersThe only 5 stocks that matterSpaceX's IPO reportedly minted 4,400 new millionaires, and OpenAI is said to be eyeing a 1 trillion dollar IPO...TradeSmith | SponsoredThey didn't warn anyone in 1971. This time someone is warning you.On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredWhy I went to Mount RushmoreA small miner just hit on gold in the hills surrounding Mount Rushmore, thanks to a breakthrough new technolog...Stansberry Research | SponsoredThe 2026 beginners Guide to Gold IRAsGold trades near record highs while silver just topped $81 an ounce for the first time ever. Thousands of A...Goldco Direct, LLC | SponsoredEvery Major Market Reset Had These 3 Warning Signs First. All 3 Are Flashing Right Now.U.S. debt is closing in on 38 trillion as foreign buyers pull back, tightening liquidity across markets. Th...Golden Crest Metals | SponsoredHow options let you do more with less capitalWould you rather spend $5,000 buying 100 shares of a $50 stock, or control those same 100 shares for a fractio...Base Camp Trading | SponsoredThe Flaw Your Financial Advisor Will Not NameThe U.S. government values its gold at $42 an ounce, a price set by Congress in 1973 and never updated. Gold t...Monetary Gold | SponsoredMy next big call (under $1)17,556% on KDA. Here's what I'm buying now. It's a coin under $1.00 that most investors have never heard of...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Eisai Co., Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Eisai With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
